Amicus Therapeutics Inc. (Nasdaq: FOLD) accelerated its regulatory approval filing timeline sending the stock price soaring $3.08 to $12.43.
Amicus accelerates filing timeline
March 19, 2015 at 12:47 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.